TCL Archive NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects November 12, 1976
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board February 1, 1991